Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Chief Executive Officer, Director | $2.51M | -$255K | -9.22% | Dec 16, 2024 |
RVMD, RVMDW | Revolution Medicines, Inc. | Director | $1.08M | -$445K | -29.2% | Oct 31, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|